TASE:NVLGHealthcare
Novolog (TASE:NVLG) One Off ₪21.7m Loss Reinforces Bearish Profitability Narratives
Novolog (Pharm-Up 1966) (TASE:NVLG) opened 2026 with Q1 revenue of ₪505.8 million and basic EPS of ₪0.000864, alongside trailing 12 month revenue of ₪1.8 billion and EPS of ₪0.006938 that frame a very slim profit profile. Over recent quarters the company has seen revenue move between ₪373.3 million and ₪538.9 million, while quarterly basic EPS has ranged from a loss equivalent of ₪0.011018 per share to a gain of ₪0.009353. This leaves investors focused on how much of that top line is actually...